GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SeaSpine Holdings Corp (NAS:SPNE) » Definitions » Current Ratio

SeaSpine Holdings (SeaSpine Holdings) Current Ratio : 3.18 (As of Sep. 2022)


View and export this data going back to 2015. Start your Free Trial

What is SeaSpine Holdings Current Ratio?

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. SeaSpine Holdings's current ratio for the quarter that ended in Sep. 2022 was 3.18.

SeaSpine Holdings has a current ratio of 3.18. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.

The historical rank and industry rank for SeaSpine Holdings's Current Ratio or its related term are showing as below:

SPNE' s Current Ratio Range Over the Past 10 Years
Min: 1.46   Med: 3.6   Max: 5.9
Current: 3.18

During the past 10 years, SeaSpine Holdings's highest Current Ratio was 5.90. The lowest was 1.46. And the median was 3.60.

SPNE's Current Ratio is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 2.715 vs SPNE: 3.18

SeaSpine Holdings Current Ratio Historical Data

The historical data trend for SeaSpine Holdings's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SeaSpine Holdings Current Ratio Chart

SeaSpine Holdings Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Current Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.30 4.52 3.16 5.24 3.70

SeaSpine Holdings Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Current Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.34 3.70 2.71 3.49 3.18

Competitive Comparison of SeaSpine Holdings's Current Ratio

For the Medical Devices subindustry, SeaSpine Holdings's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SeaSpine Holdings's Current Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SeaSpine Holdings's Current Ratio distribution charts can be found below:

* The bar in red indicates where SeaSpine Holdings's Current Ratio falls into.



SeaSpine Holdings Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

SeaSpine Holdings's Current Ratio for the fiscal year that ended in Dec. 2021 is calculated as

Current Ratio (A: Dec. 2021 )=Total Current Assets (A: Dec. 2021 )/Total Current Liabilities (A: Dec. 2021 )
=195.964/52.981
=3.70

SeaSpine Holdings's Current Ratio for the quarter that ended in Sep. 2022 is calculated as

Current Ratio (Q: Sep. 2022 )=Total Current Assets (Q: Sep. 2022 )/Total Current Liabilities (Q: Sep. 2022 )
=174.866/55.047
=3.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SeaSpine Holdings  (NAS:SPNE) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


SeaSpine Holdings Current Ratio Related Terms

Thank you for viewing the detailed overview of SeaSpine Holdings's Current Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


SeaSpine Holdings (SeaSpine Holdings) Business Description

Traded in Other Exchanges
N/A
Address
5770 Armada Drive, Carlsbad, CA, USA, 92008
SeaSpine Holdings Corp is a medical technology company. The company focuses on the design, development, and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. It has orthobiologics and spinal infusion hardware product categories. Its products are anterior and posterior fixation, access systems, bone graft substitutes, and collagen ceramic metrix. The company mainly operates in North America, Europe, Asia-Pacific, and Latin America. It generates revenue by consigning or loaning its products to hospitals and independent sales agents.
Executives
Shweta Maniar director C/O SEASPINE HOLDINGS CORP, 5770 ARMADA DRIVE, CARLSBAD CA 92008
Beau Standish officer: President, Enabling Tech C/O SEASPINE HOLDINGS CORP, 5770 ARMADA DRIVE, CARLSBAD CA 92008
Paul S. Benny officer: VP, Corporate Controller C/O SEASPINE HOLDINGS CORPORATION, 5770 ARMADA DRIVE, CARLSBAD CA 92008
Renee Gaeta director C/O MOTIVA USA LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Angela Steinway director C/O SEASPINE HOLDINGS CORP, 5770 ARMADA DRIVE, CARLSBAD CA 92008
Michael Fekete director C/O SAGENT PHARMACEUTICALS, INC., 1901 NORTH ROSELLE ROAD, SUITE 700, SCHAUMBURG IL 60195
Tru St Partnership, L.p. 10 percent owner 795 EAST LANCASTER AVE., STE. 200, VILLANOVA PA 19085
Henneman John B Iii director 311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Richard E Caruso 10 percent owner 311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Keith Valentine officer: Chief Executive Officer 7475 LUSK BLVD., SAN DIEGO CA 92121
Kimberly Jo Tzoumakas director 1170 FAIRFAX STREET, BIRMINGHAM MI 48009
Stuart Essig director 311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Dennis Cirino officer: Senior VP, Spinal Systems 2361 LOZANA RD, DEL MAR CA 92014
Keith Bradley director
Tyler Lipschultz officer: SVP, Orthobiologics and BD 7475 LUSK BLVD, SAN DIEGO CA 92121